0001209191-18-003113.txt : 20180110
0001209191-18-003113.hdr.sgml : 20180110
20180110161148
ACCESSION NUMBER: 0001209191-18-003113
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180108
FILED AS OF DATE: 20180110
DATE AS OF CHANGE: 20180110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GROENHUYSEN WILHELMUS CM
CENTRAL INDEX KEY: 0001264783
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 18521640
MAIL ADDRESS:
STREET 1: C/O NAVTEQ CORPORATION
STREET 2: 222 MERCHANDISE MART STE 900
CITY: CHICAGO
STATE: IL
ZIP: 60654
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Novocure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4YE
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4YE
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-08
0
0001645113
Novocure Ltd
NVCR
0001264783
GROENHUYSEN WILHELMUS CM
C/O NOVOCURE INC.,
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
0
1
0
0
Chief Financial Officer
Ordinary Shares
2018-01-08
4
A
0
310
15.045
A
240210
D
Ordinary Shares
2018-01-09
4
S
0
31132
21.0194
D
209078
D
The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2017 through December 31, 2017. This transaction is also exempt under Rule 16b-3(c).
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 3, 2017.
On January 9, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 31,132 shares in multiple trades at prices ranging from $21.00 to $21.05. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
/s/ Todd Longsworth, Attorney in fact for Wilhelmus CM Groenhuysen
2018-01-10